A major milestone for Accession Therapeutics, and a fairly huge personal milestone, also. www.accessiontherapeutics.com/post/accessi...
Accession Therapeutics doses first patient in Phase 1 clinical trial of TROCEPT-01 (ATTR-01), a novel cancer immunotherapy
Accession Therapeutics Limited, a biopharmaceutical company developing next generation cancer immunotherapies, today announced it has dosed the first patient in its Phase I clinical trial evaluating T...
accessiontherapeutics.com
Exciting news, and a huge amount of effort and dedication from all involved . www.cardiff.ac.uk/news/view/29...
First patient recruited in clinical trial using cancer-targeting virus
The ATTEST trial is using a pioneering virus technology to infect cancer cells.
cardiff.ac.uk
An incredibly proud moment, and a nice way to wrap up 2025. I am indebted to the incredibly talented and dedicated VITAL team (pictured) and our commercial partners at Accession Therapeutics for delivering. www.cardiff.ac.uk/news/view/29...
Special thanks to @cancerwales.bsky.social and @cancerresearchuk.org who funded the early work on the development of this agent, and without which this agent would never have been created.
First patient recruited in clinical trial using cancer-targeting virus
The ATTEST trial is using a pioneering virus technology to infect cancer cells.
cardiff.ac.uk
As a guest editor for @JoVEJournal, I am organising a collection titled "Advances and techniques in the development of cancer immuno- and viral therapies. Interested in contributing? Please submit an abstract to app.jove.com/methods-coll...
JoVE Methods Collections
JoVE publishes peer-reviewed scientific video protocols to accelerate biological, medical, chemical and physical research. Watch our scientific video articles.
app.jove.com
Very excited our paper describing the development of a precision Virotherapy directly delivering bispecific molecules to tumour cells is in it's final polished form! www.cell.com/molecular-th...
An αvβ6-specific virotherapy expressing bispecific immune cell activators induces immune cell activation to mediate tumor cell death
Virotherapies can deliver anti-cancer therapeutics directly to tumors. Bayliss and colleagues develop a precision virotherapy expressing bispecific immunotherapies from tumor cells resulting in immune...
cell.com
As a guest editor for @JoVEJournal, I am organising a collection titled "Advances and techniques in the development of cancer immuno- and viral therapies. Interested in contributing? Please submit an abstract to app.jove.com/methods-coll...
JoVE Methods Collections
JoVE publishes peer-reviewed scientific video protocols to accelerate biological, medical, chemical and physical research. Watch our scientific video articles.
app.jove.com
Well, this is exciting, and has been a long time in the making. Many thanks to the many, many exceptional authors for their expert contributions. Would make a lovely Easter gift....(who needs chocolate eggs, right...?)
Congratulations to @gw4biomeddtp.bsky.social @atwales.bsky.social funded PhD student Rosie Mundy, presenting her groundbreaking structural and transcriptomic analysis of Ad10 today at the International Adenovirus Meeting at @cardiffunilib.bsky.social centre for student life.
Wait until you see our own pop-up shop that is going to open directly opposite the Oasis merch store on 7th July. 👉🏼 www.superbugs.online/pop-up-2025 @visitcardiff.bsky.social
